155 related articles for article (PubMed ID: 21043840)
21. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
22. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
Thomas S; Metcalfe P; Goodall AH; Gray E
Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
[TBL] [Abstract][Full Text] [Related]
24. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Huang TF; Chang CH; Ho PL; Chung CH
Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
[TBL] [Abstract][Full Text] [Related]
25. Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies.
Escher R; Vogel M; Escher G; Miescher S; Stadler BM; Berchtold P
J Autoimmun; 2002 Feb; 18(1):71-81. PubMed ID: 11869049
[TBL] [Abstract][Full Text] [Related]
26. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
[TBL] [Abstract][Full Text] [Related]
27. [Generation of human Fab antibody against platelet membrane glycoprotein IIb/IIIa and its effect on platelet aggregation].
Dong NZ; Cui YJ; Ruan CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jan; 25(1):65-7. PubMed ID: 19126390
[TBL] [Abstract][Full Text] [Related]
28. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
29. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
30. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
[TBL] [Abstract][Full Text] [Related]
31. Fab-mediated binding of glycoprotein Ib/IX and IIb/IIIa specific antibodies in chronic idiopathic thrombocytopenic purpura.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Br J Haematol; 1995 Dec; 91(4):944-50. PubMed ID: 8547147
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of platelet aggregation induced by a monoclonal antibody requiring Fc portion.
Yu AX; Wu XW; Li JZ; Lian EC
Thromb Res; 1993 Apr; 70(1):51-65. PubMed ID: 7685551
[TBL] [Abstract][Full Text] [Related]
33. Analysis of CD9, CD32 and p67 signalling: use of degranulated platelets indicates direct involvement of CD9 and p67 in integrin activation.
Slupsky JR; Cawley JC; Kaplan C; Zuzel M
Br J Haematol; 1997 Feb; 96(2):275-86. PubMed ID: 9029013
[TBL] [Abstract][Full Text] [Related]
34. The Membrane Glycoprotein IIb/IIIa Complex Mediates Deposition of Thrombin-stimulated Blood Platelets on Polystyrene Plastic Under Static Conditions.
Røger M; Høgåsen K; Mollnes TE; Hovig T
Platelets; 1994; 5(2):96-104. PubMed ID: 21043610
[TBL] [Abstract][Full Text] [Related]
35. Vitronectin inhibits blood platelet aggregation.
Røger M; Høgåsen K; Solum NO; Mollnes TE; Hovig T
Platelets; 1993; 4(4):225-9. PubMed ID: 21043846
[TBL] [Abstract][Full Text] [Related]
36. A close spatial relationship between GP IIb-IIIa complexes and CD9 antigen as demonstrated by the MAIPA technique.
Laroche-Traineau J; Macchi L; Marit G; Nurden P; Nurden AT; Clofent-Sanchez G
Platelets; 1996; 7(5-6):303-11. PubMed ID: 21043666
[TBL] [Abstract][Full Text] [Related]
37. Platelet HDL(3) binding sites are not related to integrin alpha(IIb)beta(3) (GPIIb-IIIa).
Pedreño J; de Castellarnau C; Masana L
Atherosclerosis; 2001 Jan; 154(1):23-9. PubMed ID: 11137079
[TBL] [Abstract][Full Text] [Related]
38. Membrane glycoproteins and platelet cytoskeleton in immune complex-induced platelet activation.
Kang J; Cabral C; Kushner L; Salzman EW
Blood; 1993 Mar; 81(6):1505-12. PubMed ID: 8453097
[TBL] [Abstract][Full Text] [Related]
39. Thrombospondin-induced adhesion of human platelets.
Tuszynski GP; Kowalska MA
J Clin Invest; 1991 Apr; 87(4):1387-94. PubMed ID: 2010551
[TBL] [Abstract][Full Text] [Related]
40. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
